Table 2 Baseline Characteristics
Characteristic | Audit (%) | IBD Database (%) | P value |
|---|---|---|---|
Sex (Female) | 50 | 41 | 0.12 |
Diagnosis | Â | Â | Â |
   Crohn's disease | 74 | 70 | 0.4 |
   Ulcerative colitis | 23 | 19 | 0.4 |
   Indeterminate colitis | 3 | 11 | 0.01 |
Length time since diagnosis (range: years) | Â | Â | Â |
   ≤ 5years | 64 | 55 | 0.12 |
   ≥6 years | 36 | 45 | 0.12 |
Medication exposure (ever)* | Â | Â | Â |
   Oral steroids (> 3 months duration) | 77 |  |  |
   Antiinflammatory (sulphasalazine/osalazine/mesalazine) | 88 |  |  |
   Immunosuppressive (azothioprine or methotrexate) | 59 |  |  |
   Biologic therapy (Anti TNF Infliximab) | 20 |  |  |